cellular immunogen (ImmunoGen Inc)
90
Structured Review
ImmunoGen Inc
cellular immunogen
Cellular Immunogen, supplied by ImmunoGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cellular+immunogen/t+cell+immunogen/us12018078-388-36-31
Average 90 stars, based on 1 article reviews
Cellular Immunogen, supplied by ImmunoGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cellular+immunogen/t+cell+immunogen/us12018078-388-36-31
Average 90 stars, based on 1 article reviews
cellular immunogen - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Sequencing:Article Title: SEMA4D antibody, preparation method therefor and use thereof Article Snippet: Article Title: TRAIL Deficiency Does Not Rescue Impaired CD8 + T Cell Memory Generated in the Absence of CD4 + T Cell Help Article Snippet: Using a cellular Article Title: Compositions and methods for tumour therapy Article Snippet: One method of using the vectors, provided by this invention, is to prepare a cellular immunogen such as a vaccine from tumour cells derived from one or more individuals by treating such tumour cells with a vector for downregulating osteonectin, and to administer this as an immunogen or vaccine for treatment of other subjects, e.g. patients. Clone Assay:Article Title: SEMA4D antibody, preparation method therefor and use thereof Article Snippet: Article Title: TRAIL Deficiency Does Not Rescue Impaired CD8 + T Cell Memory Generated in the Absence of CD4 + T Cell Help Article Snippet: Using a cellular Article Title: Compositions and methods for tumour therapy Article Snippet: One method of using the vectors, provided by this invention, is to prepare a cellular immunogen such as a vaccine from tumour cells derived from one or more individuals by treating such tumour cells with a vector for downregulating osteonectin, and to administer this as an immunogen or vaccine for treatment of other subjects, e.g. patients. Plasmid Preparation:Article Title: SEMA4D antibody, preparation method therefor and use thereof Article Snippet: Article Title: TRAIL Deficiency Does Not Rescue Impaired CD8 + T Cell Memory Generated in the Absence of CD4 + T Cell Help Article Snippet: Using a cellular Article Title: Compositions and methods for tumour therapy Article Snippet: One method of using the vectors, provided by this invention, is to prepare a cellular immunogen such as a vaccine from tumour cells derived from one or more individuals by treating such tumour cells with a vector for downregulating osteonectin, and to administer this as an immunogen or vaccine for treatment of other subjects, e.g. patients. Cloning:Article Title: SEMA4D antibody, preparation method therefor and use thereof Article Snippet: Article Title: TRAIL Deficiency Does Not Rescue Impaired CD8 + T Cell Memory Generated in the Absence of CD4 + T Cell Help Article Snippet: Using a cellular Article Title: Compositions and methods for tumour therapy Article Snippet: One method of using the vectors, provided by this invention, is to prepare a cellular immunogen such as a vaccine from tumour cells derived from one or more individuals by treating such tumour cells with a vector for downregulating osteonectin, and to administer this as an immunogen or vaccine for treatment of other subjects, e.g. patients. Virus:Article Title: SEMA4D antibody, preparation method therefor and use thereof Article Snippet: Article Title: TRAIL Deficiency Does Not Rescue Impaired CD8 + T Cell Memory Generated in the Absence of CD4 + T Cell Help Article Snippet: Using a cellular Article Title: Compositions and methods for tumour therapy Article Snippet: One method of using the vectors, provided by this invention, is to prepare a cellular immunogen such as a vaccine from tumour cells derived from one or more individuals by treating such tumour cells with a vector for downregulating osteonectin, and to administer this as an immunogen or vaccine for treatment of other subjects, e.g. patients. Infection:Article Title: SEMA4D antibody, preparation method therefor and use thereof Article Snippet: Article Title: TRAIL Deficiency Does Not Rescue Impaired CD8 + T Cell Memory Generated in the Absence of CD4 + T Cell Help Article Snippet: Using a cellular Article Title: Compositions and methods for tumour therapy Article Snippet: One method of using the vectors, provided by this invention, is to prepare a cellular immunogen such as a vaccine from tumour cells derived from one or more individuals by treating such tumour cells with a vector for downregulating osteonectin, and to administer this as an immunogen or vaccine for treatment of other subjects, e.g. patients. In Vitro:Article Title: SEMA4D antibody, preparation method therefor and use thereof Article Snippet: Article Title: TRAIL Deficiency Does Not Rescue Impaired CD8 + T Cell Memory Generated in the Absence of CD4 + T Cell Help Article Snippet: Using a cellular Article Title: Compositions and methods for tumour therapy Article Snippet: One method of using the vectors, provided by this invention, is to prepare a cellular immunogen such as a vaccine from tumour cells derived from one or more individuals by treating such tumour cells with a vector for downregulating osteonectin, and to administer this as an immunogen or vaccine for treatment of other subjects, e.g. patients. Derivative Assay:Article Title: SEMA4D antibody, preparation method therefor and use thereof Article Snippet: Article Title: TRAIL Deficiency Does Not Rescue Impaired CD8 + T Cell Memory Generated in the Absence of CD4 + T Cell Help Article Snippet: Using a cellular Article Title: Compositions and methods for tumour therapy Article Snippet: One method of using the vectors, provided by this invention, is to prepare a cellular immunogen such as a vaccine from tumour cells derived from one or more individuals by treating such tumour cells with a vector for downregulating osteonectin, and to administer this as an immunogen or vaccine for treatment of other subjects, e.g. patients. |